http://www.unboundmedicine.com/medline/ebm/research/clopidogrelUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19926051/full_citation/The_Worry_About_Clopidogrel_"Nonresponsiveness"_Identification_and_Treatment_in_the_Post_Percutaneous_Coronary_Intervention_Patient_Gurbel PA, Tantry US, Shuldiner AR 
The Worry About Clopidogrel "Nonresponsiveness" Identification and Treatment in the Post-Percutaneous Coronary Intervention Patient. [EDITORIAL]
JACC Cardiovasc Interv 2009 Nov; 2(11):1102-1104.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19926050/full_citation/Pharmacogenetic_Testing_for_Clopidogrel_Using_the_Rapid_INFINITI_Analyzer_A_Dose_Escalation_Study_Gladding P, White H, Voss J, et al. 
Pharmacogenetic Testing for Clopidogrel Using the Rapid INFINITI Analyzer A Dose-Escalation Study. [JOURNAL ARTICLE]
JACC Cardiovasc Interv 2009 Nov; 2(11):1095-1101.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19925675/full_citation/Topical_recombinant_thrombin_at_a_concentration_of_1000_IU/mL_reliably_shortens_in_vivo_TTH_and_delivers_durable_hemostasis_in_the_presence_of_heparin_anticoagulation_and_clopidogrel_platelet_inhibition_in_a_rabbit_model_of_vascular_bleeding_Hughes SD, Bishop PD, Garcia R, et al. 
Topical recombinant thrombin at a concentration of 1000 IU/mL reliably shortens in vivo TTH and delivers durable hemostasis in the presence of heparin anticoagulation and clopidogrel platelet inhibition in a rabbit model of vascular bleeding. [JOURNAL ARTICLE]
Ann Surg Innov Res 2009 Nov 19; 3(1):14.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19925035/full_citation/Influence_of_Some_Cardiovascular_Risk_Factors_on_the_Expression_of_Platelet_Glycoprotein_IIb/IIIa_Receptors_in_Patients_with_Myocardial_Infarction_Treated_with_Antiplatelet_Drugs_under_Primary_Percutaneous_Coronary_Intervention_Konopka A, Spychalska J, Piotrowski W, et al. 
Influence of Some Cardiovascular Risk Factors on the Expression of Platelet Glycoprotein IIb/IIIa Receptors in Patients with Myocardial Infarction Treated with Antiplatelet Drugs under Primary Percutaneous Coronary Intervention. [JOURNAL ARTICLE]
Mol Diagn Ther 2009 Dec 1; 13(6):375-382.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19923312/full_citation/Review_of_recent_evidence:_Potential_interaction_between_clopidogrel_and_proton_pump_inhibitors_Last EJ, Sheehan AH 
Review of recent evidence: Potential interaction between clopidogrel and proton pump inhibitors. [JOURNAL ARTICLE]
Am J Health Syst Pharm 2009 Dec 1; 66(23):2117-2122.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19923168/full_citation/Randomized_Double_Blind_Assessment_of_the_ONSET_and_OFFSET_of_the_Antiplatelet_Effects_of_Ticagrelor_Versus_Clopidogrel_in_Patients_With_Stable_Coronary_Artery_Disease__Randomized_Double_Blind_Assessment_of_the_ONSET_and_OFFSET_of_the_Antiplatelet_Effects_of_Ticagrelor_Versus_Clopidogrel_in_Patients_With_Stable_Cornonary_Disease:_The_ONSET/OFFSET_Study_Gurbel PA, Bliden KP, Butler K, et al. 
Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease. Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Cornonary Disease: The ONSET/OFFSET Study. [JOURNAL ARTICLE]
Circulation 2009 Nov 18.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19920055/full_citation/The_Effect_of_Ethanol_on_Oral_Cocaine_Pharmacokinetics_Reveals_an_Unrecognized_Class_of_Ethanol_Mediated_Drug_Interactions_Parker RB, Laizure SC 
The Effect of Ethanol on Oral Cocaine Pharmacokinetics Reveals an Unrecognized Class of Ethanol-Mediated Drug Interactions. [JOURNAL ARTICLE]
Drug Metab Dispos 2009 Nov 17.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19919843/full_citation/Impact_of_genetic_and_acquired_alteration_in_cytochrome_P450_system_on_pharmacologic_and_clinical_response_to_clopidogrel_Ma TK, Lam YY, Tan VP, et al. 
Impact of genetic and acquired alteration in cytochrome P450 system on pharmacologic and clinical response to clopidogrel. [JOURNAL ARTICLE]
Pharmacol Ther 2009 Nov 14.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19917893/full_citation/Letter_by_Kan_et_al_regarding_Article_"randomized_trial_of_warfarin_aspirin_and_clopidogrel_in_patients_with_chronic_heart_failure:_the_Warfarin_and_Antiplatelet_Therapy_in_Chronic_Heart_failure__WATCH__trial"_Kan LP, Chu KM, Lin GM 
Letter by Kan et al regarding Article, "randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart failure (WATCH) trial". [Comment, Letter]
Circulation 2009 Nov 17; 120(20):e164.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19917884/full_citation/High_Residual_Platelet_Reactivity_After_Clopidogrel_Loading_and_Long_Term_Clinical_Outcome_After_Drug_Eluting_Stenting_for_Unprotected_Left_Main_Coronary_Disease_Migliorini A, Valenti R, Marcucci R, et al. 
High Residual Platelet Reactivity After Clopidogrel Loading and Long-Term Clinical Outcome After Drug-Eluting Stenting for Unprotected Left Main Coronary Disease. [JOURNAL ARTICLE]
Circulation 2009 Nov 16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles